SHIVOM is building the largest genomic and health data hub around the globe by combining blockchain, genomic DNA sequencing, artificial intelligence and cryptography to power secure and personalized medicine. Everybody will be able to get their genome sequenced and securely stored, and our ecosystem will offer an open web-marketplace for providers to add their apps and services alongside advanced data analytics. The SHIVOM platform works on principles of collaboration and integrity, allowing people to own, manage and monetize their genomics and health data. As we build this global healthcare ecosystem, we will reach even underserved and low-income countries where such services have not been previously available. Our solution will create shared value for individuals, not-for-profit organizations, governments, and for-profit entities alike. The platform is truly pioneering in the way it utilizes blockchain technology, to protect, secure and monetize the donor’s DNA data to drive precision medicine and healthcare forward.
'Tael is a digital token for safe consumer products. Thanks to its ability to be seamlessly integrated by third parties, it allows for a wide token use-case through interchangeability of the loyalty tokens on the blockchain. Tael’s first use-case is seen in Techrock’s safe consumer products ecosystem. Techrock applies banking-level, tamper-proof NFC smart-labels to consumer goods, pairing them with their digital representations on the blockchain. Consumers ‘touch’ the label with their smartphones to verify a product’s authenticity, discover the product’s journey along the supply chain, and be rewarded for their purchase. Techrock protects products where authenticity matters, such as infant formula, cosmetics, alcohol, and supplements. Tael tokens are used in the loyalty point ecosystem to reward consumers and encourage behavior in the Techrock channel while generating unique data for all companies in the value chain. Tael’s vision is to bring blockchain based payments into the mainstream, across Asia and beyond.'